I would probably not use the risk score calculator to determine if one of my patients should use or not use semaglutide, said Ali
More severe side effects are also possible, depending on several factors including age and preexisting conditions
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
To improve uptake: If youre traveling or have an irregular schedule, plan ahead
If you are still unsure, start with Thursday evening
The SURMOUNT-1 trial provides the most comprehensive data